NCT03527927View on ClinicalTrials.gov

sTep dOWn Inhalers in the reAl woRlD

NACompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

May 17, 2017

Primary Completion Date

August 26, 2019

Study Completion Date

August 26, 2019

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Any LABA/LAMA

Following consent, patients will be taken off their current ICS/LABA/LAMA combination inhalers and shown 4 single inhaler LABA/LAMA devices and asked to choose a preferred device to use, provided they can demonstrate effective use.

Trial Locations (1)

SA148QF

Prince Philip Hospital, Llanelli

All Listed Sponsors
collaborator

Swansea University

OTHER

lead

Hywel Dda Health Board

OTHER

NCT03527927 - sTep dOWn Inhalers in the reAl woRlD | Biotech Hunter | Biotech Hunter